Bochum, Germany
WallabyPhenox, a rebranded entity following its 2022 acquisition by Wallaby Medical, is a leading innovator in the realm of interventional neuroradiology. Originally established in 2005 under the name phenox GmbH, the company has consistently pursued the development of groundbreaking technologies for neurovascular disease treatment.
Their premier product lineup includes the Mechanical Thrombectomy System pRESET, along with the p64, p48 MW, and p64 MW Flow Diverters designed for complex intracranial aneurysms. Another standout, the pCONUS Implant, addresses wide-neck bifurcation aneurysms. A highlight is their HPC Technology, which dramatically enhances patient safety by minimizing implant thrombogenicity.
Operating from their headquarters in Germany, the company’s integrative approach to neurovascular solutions is underscored by its exclusive distribution of the Avenir Coiling System. Their last major financial activity was their acquisition by Wallaby Medical on 01 April 2022.